CSS
TMO icon

Cubist Systematic Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Cubist Systematic Strategies’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12M Sell
24,700
-34,200
-58% -$15.9M 0.06% 472
2025
Q2 		$23.9M Buy
58,900
+53,600
+1,011% +$22.4M 0.11% 239
2025
Q1 		$2.64M Sell
5,300
-11,500
-68% -$6.23M 0.02% 1259
2024
Q4 		$8.74M Buy
16,800
+10,500
+167% +$5.77M 0.05% 532
2024
Q3 		$3.9M Sell
6,300
-1,000
-14% -$592K 0.02% 989
2024
Q2 		$4.04M Sell
7,300
-5,400
-43% -$3.09M 0.03% 913
2024
Q1 		$7.38M Sell
12,700
-4,600
-27% -$2.58M 0.04% 707
2023
Q4 		$9.18M Buy
17,300
+10,800
+166% +$5.23M 0.06% 500
2023
Q3 		$3.29M Sell
6,500
-3,000
-32% -$1.6M 0.02% 1020
2023
Q2 		$4.96M Buy
9,500
+7,000
+280% +$3.78M 0.03% 855
2023
Q1 		$1.44M Sell
2,500
-600
-19% -$338K 0.01% 1908
2022
Q4 		$1.71M Buy
3,100
+1,900
+158% +$1.01M 0.01% 1982
2022
Q3 		$609K Sell
1,200
-3,200
-73% -$1.79M ﹤0.01% 3013
2022
Q2 		$2.39M Buy
+4,400
New +$2.42M 0.01% 1679

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cubist Systematic Strategies's TMO Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Thermo Fisher Scientific (TMO) stake by 79% in Q3 2025, selling an estimated $46.5M and leaving 26,469 shares worth $12.8M. The position accounts for 0.06% of the portfolio, ranked #442.

Cubist Systematic Strategies first reported a position in TMO in Q2 2014 and has held it in 43 quarters since. The position peaked at $53.7M in Q2 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Cubist Systematic Strategies held 26,469 shares of Thermo Fisher Scientific worth $12.8M as of Q3 2025.
  • Cubist Systematic Strategies sold 99,812 Thermo Fisher Scientific shares in Q3 2025, an estimated $46.5M.
  • Thermo Fisher Scientific made up 0.06% of Cubist Systematic Strategies's portfolio in Q3 2025, its #442 holding.
  • Cubist Systematic Strategies first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 43 quarters since.
  • Cubist Systematic Strategies's Thermo Fisher Scientific position peaked at $53.7M in Q2 2024.
  • 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.